CYTOCHROME C OXIDASE DEFICIENCIES
\sˈa͡ɪtəkɹˌə͡ʊm sˈiː ˈɒksɪdˌe͡ɪs dɪfˈɪʃənsɪz], \sˈaɪtəkɹˌəʊm sˈiː ˈɒksɪdˌeɪs dɪfˈɪʃənsɪz], \s_ˈaɪ_t_ə_k_ɹ_ˌəʊ_m s_ˈiː_ ˈɒ_k_s_ɪ_d_ˌeɪ_s d_ɪ_f_ˈɪ_ʃ_ə_n_s_ɪ_z]\
Sort: Oldest first
-
A disease that results from a congenital defect in CYTOCHROME-C OXIDASE. Defects in cytochrome-c oxidase can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. Cytochrome-c oxidase deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#220110, May 17, 2001)
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.